Inhibitors of Phosphoinositol 3 Kinase and NFκB for the Treatment of Chronic Obstructive Pulmonary Disease
| Autor: | Nancy Larocca, Dolores Moreno, Juan B. De Sanctis, Jenny V. Garmendia |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Pathology
medicine.medical_specialty COPD Phosphoinositide 3-kinase biology business.industry Kinase Disease progression Pulmonary disease Inflammation General Medicine Disease respiratory system Airway obstruction medicine.disease respiratory tract diseases Drug Discovery Immunology biology.protein Immunology and Allergy Medicine medicine.symptom business |
| Zdroj: | Recent Patents on Inflammation & Allergy Drug Discovery. 5:178-183 |
| ISSN: | 1872-213X |
| Popis: | Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized mainly by pulmonary airflow limitation that is not fully reversible. New different pharmacological approaches to decrease inflammation of the airways and consequently disease progression and increase airway obstruction reversibility have been developed. In the present article, we review the new patents on phosphoinositide 3 kinase and NFκb inhibitors for future therapies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|